TKIs are involved in treating an increasing number of cancer indications. Doctors need to be aware of the range of potentially serious side effects associated with these drugs, and know how to mitigate them, to [more]
Skin rash and itchy skin are known to be common side-effects in patients treated with EGFR and tyrosine kinase inhibitors, and can be distressing, particularly when severe. A growing understanding of why this happens is [more]
Better understanding of the different mutations that drive GIST is leading to new paradigms of tailored treatment that break many norms of chemotherapy, especially in management of progression. Download full article